Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Grant and collaboration revenue	$ 352,137	$ 166,280	$ 647,872	$ 213,880
Operating expenses:
Research and development	518,098	397,576	1,069,893	835,580
General and administrative	352,191	344,818	644,858	1,251,323
Total operating expenses	870,289	742,394	1,714,751	2,086,903
Loss from operations	(518,152)	(576,114)	(1,066,879)	(1,873,023)
Other income:
Interest income	1,271	279	1,657	909
Net loss	$ (516,881)	$ (575,835)	$ (1,065,222)	$ (1,872,114)
Basic and diluted:
Loss per common share (in dollars per share)	$ (0.01)	$ (0.02)	$ (0.02)	$ (0.05)
Weighted averages shares outstanding (in shares)	59,791,475	37,425,291	57,583,491	36,012,458